Mederi’s innovative products offer proven solutions to the debilitating digestive disorders called gastroesophageal reflux disease (GERD) and bowel control disorder (BCD). GERD and BCD collectively affect tens of millions of sufferers worldwide. Mederi Therapeutics’ products, Stretta for GERD and Secca for BCD, are minimally invasive treatments that bridge the gap between conservative measures and invasive surgery or implants. Secca and Stretta use radiofrequency (RF) energy to remodel the muscles that control the entry and exit of the human digestive system...allowing patients to experience significantly fewer symptoms and lead much more fulfilling lives.